Patents Assigned to Qingdao Vland Biotech Group Co., Ltd.
-
Publication number: 20240384252Abstract: A high temperature resistant mannanase mutant, comprising at least one mutation site among D49C/I/N, G58D/E/S, H90L, T99Y, K120Y, N124P, T130D/N/P/Q/R/S, Y132F, S136M, S140L/K, T148K, F206Y, A212N/S/P, L257F, S263R, D268A/E/G/P, G273P, S302M/E, S306M/Q, T315P, T353L/F, D360E/N/K, and A362R. The high temperature resistant mannanase mutant has heat resistance significantly higher than the wild type mannanase, and can be widely used in the field of feeds.Type: ApplicationFiled: September 16, 2022Publication date: November 21, 2024Applicant: QINGDAO VLAND BIOTECH GROUP CO., LTD.Inventors: Xiuxiu WU, Rui LI, Yuqiang LI, Yijun HUANG, Xinpei LI, Lihong XU, Qingqing SONG, Wen XIN
-
Patent number: 12018262Abstract: Provided is a method for producing washing enzyme having protease resistance. According to the method, the washing enzyme having resistance to protease is obtained by carrying out fusion expression on a gene of the washing enzyme with the gene of a protease inhibitory peptide, thereby facilitating maintaining the stability of various enzyme components in an enzyme-containing detergent, and improving the use effect of the detergent.Type: GrantFiled: October 28, 2019Date of Patent: June 25, 2024Assignee: QINGDAO VLAND BIOTECH GROUP CO., LTDInventors: Qing Zhang, Zhibing Chen, Yanping Liu, Yanjun Tian, Wei Xu, Yinan Guan, Yijun Huang, Jiahua Lyu
-
Publication number: 20240000864Abstract: Provided are a Bacillus coagulans strain VHProbi C08 having a blood glucose reduction efficacy and an application thereof in preparation of a hypoglycemic product. The accession number of the strain is CCTCCM 2019738. Further provided is a hypoglycemic product comprising the Bacillus coagulans VHProbi C08 and/or the fermentation product of Bacillus coagulans VHProbi C08. A carbon source used in the culture medium of the strain is any one or more of fructooligosaccharide, galactooligosaccharides, and inulin.Type: ApplicationFiled: June 21, 2021Publication date: January 4, 2024Applicants: QINGDAO VLAND BIOTECH INC., QINGDAO VLAND BIOTECH GROUP CO., LTD.Inventors: Zhi DUAN, Hongchang CUI, Songjie WU, Jingyan ZHANG, Luxia ZHANG
-
Patent number: 11739336Abstract: Provided are mutants PHY1, PHY4 and PHY5 of a wild-type phytase APPA. After being treated for 10 min at 80° C., the residual enzyme activities of the mutants PHY1, PHY4 and PHY5 are respectively higher by 33.85%, 53.11% and 75.86% compared with that of APPA-M; after being treated for 5 min at 85° C., the residual enzyme activities of the mutants PHY1, PHY4 and PHY5 are respectively higher by 14.89%, 28.45% and 44.94% compared with that of APPA-M, and the heat resistance of these mutants is significantly higher than that of APPA-M.Type: GrantFiled: July 28, 2021Date of Patent: August 29, 2023Assignee: Qingdao Vland Biotech Group Co., Ltd.Inventors: Xiuxiu Wu, Huaming Wang
-
Publication number: 20230242890Abstract: Provided are a phytase mutant and a coding DNA molecule thereof, a vector, and a host cell. The phytase mutant comprises an amino acid sequence having at least 90% identity with SEQ ID NO: 3, and compared with SEQ ID NO: 3, and contains an amino acid substitution at at least one position selected from the group consisting of 36, 126, 211, 253, 258, and 266. The heat resistance of the mutant is significantly improved, thus facilitating the wide application of phytase in feed.Type: ApplicationFiled: May 20, 2021Publication date: August 3, 2023Applicant: QINGDAO VLAND BIOTECH GROUP CO., LTD.Inventors: Xiuxiu WU, Xinpei LI, Rui LI, Qingqing SONG, Yijun HUANG
-
Publication number: 20220380778Abstract: Provided is a xylanase mutant having improved specific activity, comprising any one or more mutation sites of M78F, V1431, R148K, F163W, I177V, and V206L. The specific activity of the mutant is improved, the production cost of xylanase is reduced, and the mutant can be used in feed.Type: ApplicationFiled: May 15, 2020Publication date: December 1, 2022Applicant: QINGDAO VLAND BIOTECH GROUP CO., LTD.Inventors: Xiuxiu WU, Rongxi SONG, Yijun HUANG
-
Publication number: 20220154154Abstract: The present invention relates to the technical field of biology, in particular to a phytase mutant, a preparation method therefor and an application thereof, a DNA molecule encoding the phytase mutant, a vector, and a host cell. The mutant provided by the present invention contains the substituent of an amino acid at at least one position selected from the following group: 36, 69, 89, 91, 111, 202, 213, 225, 238, 243, 253, 258, and 266. The heat resistance of the mutant is significantly improved, thereby facilitating the wide application of the phytase in feed.Type: ApplicationFiled: February 11, 2020Publication date: May 19, 2022Applicant: QINGDAO VLAND BIOTECH GROUP CO., LTDInventors: Xiuxiu WU, Yijun HUANG, Yang LIU, Xia ZHANG, Sida CHENG
-
Publication number: 20220010315Abstract: Provided is a method for producing washing enzyme having protease resistance. According to the method, the washing enzyme having resistance to protease is obtained by carrying out fusion expression on a gene of the washing enzyme with the gene of a protease inhibitory peptide, thereby facilitating maintaining the stability of various enzyme components in an enzyme-containing detergent, and improving the use effect of the detergent.Type: ApplicationFiled: October 28, 2019Publication date: January 13, 2022Applicant: QINGDAO VLAND BIOTECH GROUP CO., LTDInventors: Qing ZHANG, Zhibing CHEN, Yanping LIU, Yanjun TIAN, Wei XU, Yinan GUAN, Yijun HUANG, Jiahua LYU
-
Patent number: 11214776Abstract: Provided are phytase mutants, preparation methods therefor and uses thereof, DNA molecule encoding each of the phytase mutants, a vector comprising the DNA molecule, and a host cell comprising the vector.Type: GrantFiled: August 8, 2016Date of Patent: January 4, 2022Assignee: Qingdao Vland Biotech Group Co., Ltd.Inventors: Xiuxiu Wu, Huaming Wang
-
Patent number: 11104908Abstract: Provided are mutants PHY1, PHY4 and PHY5 of a wild-type phytase APPA. After being treated for 10 min at 80° C., the residual enzyme activities of the mutants PHY1, PHY4 and PHY5 are respectively higher by 33.85%, 53.11% and 75.86% compared with that of APPA-M; after being treated for 5 min at 85° C., the residual enzyme activities of the mutants PHY1, PHY4 and PHY5 are respectively higher by 14.89%, 28.45% and 44.94% compared with that of APPA-M, and the heat resistance of these mutants is significantly higher than that of APPA-M.Type: GrantFiled: December 8, 2014Date of Patent: August 31, 2021Assignee: Qingdao Vland Biotech Group Co., Ltd.Inventors: Xiuxiu Wu, Huaming Wang
-
Patent number: 10968439Abstract: The present invention relates to the technical field of protein engineering, and, in particular, to a xylanase mutant with improved heat tolerance. The present invention artificially introduces two or three unnatural disulfide bridges into xylanase by site-directed mutagenesis and obtains the mutants XynA1 and XynA2 with improved heat tolerance, especially the mutant XynA2 into which three disulfide bridges are introduced, achieving residual enzyme activity of 75% after treatment at 80° C. for 5 min, 72% higher than the residual enzyme activity of the mutant XynA1. The present invention further obtains, by screening, three mutation sites Q51N, H143K, and Q161F that can significantly increase the heat tolerance of mutants, and introduction of the mutation sites into the XynA1 and XynA2 xylanases, whether at a single point or a combination of two points or a combination of three points, can effectively improve the heat tolerance of the mutants.Type: GrantFiled: April 19, 2018Date of Patent: April 6, 2021Assignee: QINGDAO VLAND BIOTECH GROUP CO., LTDInventors: Xiuxiu Wu, Chao Shao, Yijun Huang
-
Publication number: 20200239865Abstract: The present invention relates to the technical field of protein engineering, and, in particular, to a xylanase mutant with improved heat tolerance. The present invention artificially introduces two or three unnatural disulfide bridges into xylanase by site-directed mutagenesis and obtains the mutants XynA1 and XynA2 with improved heat tolerance, especially the mutant XynA2 into which three disulfide bridges are introduced, achieving residual enzyme activity of 75% after treatment at 80° C. for 5 min, 72% higher than the residual enzyme activity of the mutant XynA1. The present invention further obtains, by screening, three mutation sites Q51N, H143K, and Q161F that can significantly increase the heat tolerance of mutants, and introduction of the mutation sites into the XynA1 and XynA2 xylanases, whether at a single point or a combination of two points or a combination of three points, can effectively improve the heat tolerance of the mutants.Type: ApplicationFiled: April 19, 2018Publication date: July 30, 2020Applicant: QINGDAO VLAND BIOTECH GROUP CO., LTDInventors: Xiuxiu WU, Chao SHAO, Yijun HUANG
-
Patent number: 10059973Abstract: The invention provides novel carbohydrate esters, in particular disaccharide esters, and the methods of their preparation. These compounds find use as microbial media components for the induction of gene expression in microbial fermentation processes.Type: GrantFiled: July 18, 2013Date of Patent: August 28, 2018Assignee: QINGDAO VLAND BIOTECH GROUP CO., LTD.Inventor: Tom Tao Huang
-
Patent number: 9828592Abstract: The present disclosure provides a sophorolipid composition that can be used for inducing protein expression in a fermentation host. The sophorolipid composition described herein can be prepared from a natural sophorolipid mixture. Acid treatment of the natural sophorolipid mixture results in a mixture of monoacetylated, deacetylated, and/or diacetylated sophorolipids. The chemically modified sophorolipid composition, or isolated components of the chemically modified sophorolipid composition, can be used as inducers for protein production in filamentous fungi.Type: GrantFiled: November 5, 2015Date of Patent: November 28, 2017Assignee: Qingdao Vland Biotech Group Co., Ltd.Inventor: Tom Tao Huang